Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast

APMIS

Volumn 114, Issue 10, 2006, Pages 712-719

  Honma, Naoko ^a,b   Takubo, Kaiyo ^a   Arai, Tomio ^c   Younes, Mamoun ^d   Kasumi, Fujio ^e   Akiyama, Futoshi ^b   Sakamoto, Goi ^b  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b CANCER INSTITUTE   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Apocrine carcinoma; Breast; Gross cystic disease fluid protein 15 (GCDFP 15); Immunohistochemistry; Monoclonal antibody B72.3 (MAb B72.3)

Indexed keywords

GROSS CYSTIC DISEASE FLUID PROTEIN 15; MONOCLONAL ANTIBODY B.72.3; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; APOCRINE CARCINOMA; ARTICLE; BREAST CARCINOMA; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; APOCRINE GLANDS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33749265651     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_434.x     Document Type: Article

References (27)

1. Azzopardi JG, Ahmed A, Millis RR. Problems in breast pathology. Major Probl Pathol 1979;11:341-5.
2. Frable WJ, Kay S. Carcinoma of the Breast. Histologic and Clinical Features of Apocrine Tumors. Cancer 1968;21:756-63.
3. Tavassoli FA, Purcell CA, Bratthauer GL, Man Y. Androgen receptor expression along with loss of bcl-2, ER, and PR expression in benign and malignant apocrine lesions of the breast: implications for therapy. Breast J 1996;2:261-9.
4. Alsabeh R, Wilson CS, Ahn CW, Vasef MA, Battifora H. Expression of bcl-2 by breast cancer: a possible diagnostic application. Mod Pathol 1996;9:439-44.
5. Hellemans P, van Dam PA, Weyler J, van Oosterom AT, Buytaert P, Van Marck E. Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 1995;72:354-60.
6. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 1994;69:135-9.
7. Abati AD, Kimmel M, Rosen PP. Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol 1990;94:371-7.
8. d'Amore ESG, Terrier-Lacombe MJ, Travagli JP, Friedman S, Contesso G. Invasive apocrine carcinoma of the breast: a long term follow-up study of 34 cases. Breast Cancer Res Treat 1988;12:37-44.
9. Honma N, Sakamoto G, Akiyama F, Esaki Y, Sawabe M, Arai T, et al. Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status. Histopathology 2003;42:120-7.
10. Mossler JA, Barton TK, Brinkhous AD, McCarty KS, Moylan JA, McCarty KS Jr. Apocrine differentiation in human mammary carcinoma. Cancer 1980;46:2463-71.
11. Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003;36-7.
12. Haagensen DE, Stewart P, Dilley WG, Wells SA. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture - modulation by steroid hrmones. Breast Cancer Res Treat 1992;23:77-86.
13. Miller WR, Shivas AA, Franchimont P, Haagensen DE. Breast gross cystic disease protein 15 in human breast cancer in culture. Eur J Cancer Clin Oncol 1988;24:223-8.
14. Eusebi V, Millis RR, Cattani MG, Bussolati G, Azzopardi JG. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study. Am J Pathol 1986;123:532-41.
15. Mazoujian G, Pinkus GS, Davis S, Haagensen DE Jr. Immunohistochemistry of a Gross Cystic Disease Fluid Protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 1983;110:105-12.
16. Mazoujian G, Bodian C, Haagensen DE Jr, Haagensen CD. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer 1989;63:2156-61.
17. Pagani A, Sapino A, Eusebi V, Bergnolo P, Bussolati G. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch 1994;425:459-65.
18. Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, et al. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. Histopathology 2005;47:195-201.
19. Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986;46:3118-24.
20. Castagna M, Nuti M, Squartini F. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast. Cancer Res 1987;47:902-6.
21. Tavassoli FA, JonesMW, Majeste RM, Bratthauer GL, O'Leary TJ. Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease. Am J Surg Pathol 1990;14:128-33.
22. Prey MU, Bedrossian CWM, Masood S. The value of monoclonal antibody B72.3 for the diagnosis of breast carcinoma: experience with the first commercially available source. Hum Pathol 1991;22:598-602.
23. Soomro S, Shousha S. Monoclonal antibody B72.3 immunostaining of breast carcinoma. Patterns of staining and relationship to mucin content and GCDFP-15 reactivity. Arch Pathol Lab Med 1992;116:32-5.
24. Tavassoli FA, Norris HJ. Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases. Mod Pathol 1994;7:813-8.
25. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
26. Damiani S, Eusebi V, Losi L, d'Adda T, Rosai J. Oncocytic carcinoma (malignant oncocytoma) of the breast. Am J Surg Pathol 1998;22:221-30.
27. Damiani S, Dina R, Eusebi V. Eosinophilic and granular cell tumors of the breast. Semin Diagn Pathol 1999;16:117-25.